• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于临床试验的表没食子儿茶素-3-没食子酸酯(EGCG):问题多于希望?

Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?

作者信息

Mereles Derliz, Hunstein Werner

机构信息

Department of Cardiology, Angiology and Pneumology, University of Heidelberg, D-69120 Heidelberg, Germany.

出版信息

Int J Mol Sci. 2011;12(9):5592-603. doi: 10.3390/ijms12095592. Epub 2011 Aug 31.

DOI:10.3390/ijms12095592
PMID:22016611
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3189735/
Abstract

Epigallocatechin-3-gallate (EGCG), the main and most significant polyphenol in green tea, has shown numerous health promoting effects acting through different pathways, as antioxidant, anti-inflammatory and anti-atherogenic agent, showing gene expression activity, functioning through growth factor-mediated pathways, the mitogen-activated protein kinase-dependent pathway, the ubiquitin/proteasome degradation pathway, as well as eliciting an amyloid protein remodeling activity. However, epidemiological inferences are sometimes conflicting and in vitro and in vivo studies may seem discrepant. Current knowledge on how to enhance bioavailability could be the answer to some of these issues. Furthermore, dose levels, administration frequency and potential side effects remain to be examined.

摘要

表没食子儿茶素-3-没食子酸酯(EGCG)是绿茶中主要且最重要的多酚类物质,已显示出通过不同途径发挥的多种促进健康的作用,如作为抗氧化剂、抗炎剂和抗动脉粥样硬化剂,具有基因表达活性,通过生长因子介导的途径、丝裂原活化蛋白激酶依赖性途径、泛素/蛋白酶体降解途径发挥作用,以及引发淀粉样蛋白重塑活性。然而,流行病学推断有时相互矛盾,体外和体内研究结果可能存在差异。目前关于如何提高生物利用度的知识可能是解决其中一些问题的答案。此外,剂量水平、给药频率和潜在副作用仍有待研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb4/3189735/5eaf18115e83/ijms-12-05592f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb4/3189735/0bd83739ff8e/ijms-12-05592f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb4/3189735/7f4469e752bc/ijms-12-05592f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb4/3189735/5eaf18115e83/ijms-12-05592f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb4/3189735/0bd83739ff8e/ijms-12-05592f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb4/3189735/7f4469e752bc/ijms-12-05592f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb4/3189735/5eaf18115e83/ijms-12-05592f3.jpg

相似文献

1
Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?用于临床试验的表没食子儿茶素-3-没食子酸酯(EGCG):问题多于希望?
Int J Mol Sci. 2011;12(9):5592-603. doi: 10.3390/ijms12095592. Epub 2011 Aug 31.
2
Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.给药条件对健康个体单次服用Polyphenon E后绿茶儿茶素口服生物利用度的影响。
Clin Cancer Res. 2005 Jun 15;11(12):4627-33. doi: 10.1158/1078-0432.CCR-04-2549.
3
Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.用绿茶多酚(-)-表没食子儿茶素-3-没食子酸酯进行饮食预处理可降低随后口服大剂量(-)-表没食子儿茶素-3-没食子酸酯的生物利用度和肝毒性。
Food Chem Toxicol. 2015 Feb;76:103-8. doi: 10.1016/j.fct.2014.12.009. Epub 2014 Dec 17.
4
Curcumin as a permeability enhancer enhanced the antihyperlipidemic activity of dietary green tea extract.姜黄素作为一种通透性增强剂增强了膳食绿茶提取物的降血脂活性。
BMC Complement Altern Med. 2019 Jun 13;19(1):129. doi: 10.1186/s12906-019-2545-1.
5
Identification of the Catechin Uptake Transporter Responsible for Intestinal Absorption of Epigallocatechin Gallate in Mice.鉴定负责肠道吸收表没食子儿茶素没食子酸酯的儿茶素摄取转运体。
Sci Rep. 2019 Jul 29;9(1):11014. doi: 10.1038/s41598-019-47214-4.
6
Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn.表没食子儿茶素没食子酸酯,一种绿茶多酚,利用血管内皮中需要活性氧和Fyn的信号通路介导一氧化氮依赖性血管舒张。
J Biol Chem. 2007 May 4;282(18):13736-45. doi: 10.1074/jbc.M609725200. Epub 2007 Mar 15.
7
Green tea polyphenol, (-)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting β-catenin signaling.绿茶多酚,(-)-表没食子儿茶素-3-没食子酸酯,通过靶向β-连环蛋白信号诱导人皮肤癌细胞毒性。
Toxicol Appl Pharmacol. 2013 Dec 1;273(2):418-24. doi: 10.1016/j.taap.2013.09.021. Epub 2013 Oct 3.
8
Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma.茶儿茶素、(-)-表没食子儿茶素-3-没食子酸酯和(-)-表没食子儿茶素在人体血浆中的剂量依赖性掺入。
Biosci Biotechnol Biochem. 1997 Dec;61(12):1981-5. doi: 10.1271/bbb.61.1981.
9
New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate.多酚类物质抗氧化特性之外作用机制的新见解;来自绿茶多酚表没食子儿茶素没食子酸酯的启示
Redox Biol. 2014 Jan 10;2:187-95. doi: 10.1016/j.redox.2013.12.022. eCollection 2014.
10
Bioactive peptides/chitosan nanoparticles enhance cellular antioxidant activity of (-)-epigallocatechin-3-gallate.生物活性肽/壳聚糖纳米粒子增强了 (-)-表没食子儿茶素-3-没食子酸酯的细胞抗氧化活性。
J Agric Food Chem. 2013 Jan 30;61(4):875-81. doi: 10.1021/jf304821k. Epub 2013 Jan 17.

引用本文的文献

1
Integrating network pharmacology, bioinformatics and molecular docking to explore the anti-NSCLC mechanisms of EGCG in green tea.整合网络药理学、生物信息学和分子对接技术以探究绿茶中表没食子儿茶素没食子酸酯(EGCG)抗非小细胞肺癌(NSCLC)的机制。
Medicine (Baltimore). 2025 Sep 5;104(36):e44070. doi: 10.1097/MD.0000000000044070.
2
Green tea's secret weapon: a review on the protective effects of epigallocatechin-3-gallate against ischemia/reperfusion damage.绿茶的秘密武器:表没食子儿茶素-3-没食子酸酯对缺血/再灌注损伤保护作用的综述
Pharmacol Rep. 2025 Sep 5. doi: 10.1007/s43440-025-00781-y.
3
Catechins and Human Health: Breakthroughs from Clinical Trials.

本文引用的文献

1
Degradation kinetics of catechins in green tea powder: effects of temperature and relative humidity.绿茶粉中儿茶素的降解动力学:温度和相对湿度的影响。
J Agric Food Chem. 2011 Jun 8;59(11):6082-90. doi: 10.1021/jf200203n. Epub 2011 May 10.
2
EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment.EGCG、绿茶多酚及其合成类似物和前药在人类癌症预防和治疗中的应用。
Adv Clin Chem. 2011;53:155-77. doi: 10.1016/b978-0-12-385855-9.00007-2.
3
Green tea polyphenol epigallocatechin-3-gallate inhibits TLR2 signaling induced by peptidoglycan through the polyphenol sensing molecule 67-kDa laminin receptor.
儿茶素与人类健康:临床试验的突破
Molecules. 2025 Jul 25;30(15):3128. doi: 10.3390/molecules30153128.
4
Phytotherapy and the Role of Bioactive Compounds in Modulating Mechanisms of Overweight and Obesity Comorbid with Depressive Symptoms-A Scoping Review of Mechanisms of Action.植物疗法及生物活性化合物在调节伴有抑郁症状的超重和肥胖机制中的作用——作用机制的范围综述
Molecules. 2025 Jun 30;30(13):2827. doi: 10.3390/molecules30132827.
5
The Dual Role of Dietary Phytochemicals in Oxidative Stress: Implications for Oncogenesis, Cancer Chemoprevention, and ncRNA Regulation.膳食植物化学物质在氧化应激中的双重作用:对肿瘤发生、癌症化学预防和非编码RNA调控的影响
Antioxidants (Basel). 2025 May 22;14(6):620. doi: 10.3390/antiox14060620.
6
Nanoparticle-mediated delivery of herbal-derived natural products to modulate immunosenescence-induced drug resistance in cancer therapy: a comprehensive review.纳米颗粒介导的草药衍生天然产物递送在癌症治疗中调节免疫衰老诱导的耐药性:综述
Front Oncol. 2025 Apr 28;15:1567896. doi: 10.3389/fonc.2025.1567896. eCollection 2025.
7
Phytochemicals as Chemo-Preventive and Therapeutic Agents Against Bladder Cancer: A Comprehensive Review.植物化学物质作为膀胱癌的化学预防和治疗剂:综述
Diseases. 2025 Mar 30;13(4):103. doi: 10.3390/diseases13040103.
8
Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential.表没食子儿茶素没食子酸酯(EGCG):药理特性、生物活性及治疗潜力
Molecules. 2025 Feb 1;30(3):654. doi: 10.3390/molecules30030654.
9
Natural products against tau hyperphosphorylation-induced aggregates: Potential therapies for Alzheimer's disease.针对tau蛋白过度磷酸化诱导的聚集体的天然产物:阿尔茨海默病的潜在疗法。
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400721. doi: 10.1002/ardp.202400721.
10
Hydroxysafflor yellow A: a natural pigment with potential anticancer therapeutic effect.羟基红花黄色A:一种具有潜在抗癌治疗作用的天然色素。
Front Pharmacol. 2025 Jan 14;15:1495393. doi: 10.3389/fphar.2024.1495393. eCollection 2024.
绿茶多酚表没食子儿茶素没食子酸酯通过多酚感应分子 67kDa 层粘连蛋白受体抑制肽聚糖诱导的 TLR2 信号通路。
FEBS Lett. 2011 Mar 9;585(5):814-20. doi: 10.1016/j.febslet.2011.02.010. Epub 2011 Feb 12.
4
Human serum albumin as an antioxidant in the oxidation of (-)-epigallocatechin gallate: participation of reversible covalent binding for interaction and stabilization.人血清白蛋白在(-)-表没食子儿茶素没食子酸酯氧化过程中作为抗氧化剂:可逆共价结合参与相互作用和稳定作用。
Biosci Biotechnol Biochem. 2011;75(1):100-6. doi: 10.1271/bbb.100600. Epub 2011 Jan 7.
5
Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate.壳聚糖纳米粒增强了绿茶儿茶素(+)-儿茶素和(-)-表没食子儿茶素没食子酸酯的肠道吸收。
Eur J Pharm Sci. 2010 Oct 9;41(2):219-25. doi: 10.1016/j.ejps.2010.06.010. Epub 2010 Jun 19.
6
Environment. Endosulfan's exit: U.S. EPA pesticide review leads to a ban.环境。硫丹的退出:美国环境保护局的农药审查导致禁令。
Science. 2010 Jun 18;328(5985):1466. doi: 10.1126/science.328.5985.1466.
7
TLR4 signaling inhibitory pathway induced by green tea polyphenol epigallocatechin-3-gallate through 67-kDa laminin receptor.由绿茶多酚表没食子儿茶素没食子酸酯通过 67kDa 层粘连蛋白受体诱导的 TLR4 信号转导抑制通路。
J Immunol. 2010 Jul 1;185(1):33-45. doi: 10.4049/jimmunol.0903742. Epub 2010 May 28.
8
EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity.EGCG 重塑成熟的 α-突触核蛋白和淀粉样-β 纤维,并降低细胞毒性。
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7710-5. doi: 10.1073/pnas.0910723107. Epub 2010 Apr 12.
9
Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis.主要绿茶多酚表没食子儿茶素没食子酸酯对 AL 淀粉样变性患者心脏受累的影响。
Clin Res Cardiol. 2010 Aug;99(8):483-90. doi: 10.1007/s00392-010-0142-x. Epub 2010 Mar 10.
10
Formulation with ascorbic acid and sucrose modulates catechin bioavailability from green tea.含有抗坏血酸和蔗糖的配方可调节绿茶中儿茶素的生物利用度。
Food Res Int. 2010 Jan 1;43(1):95-102. doi: 10.1016/j.foodres.2009.08.016.